Navigation Links
Vaginal Mesh and Kugel Hernia Mesh Case Applications for Lawsuit Funding on the Rise at Legal-Bay Settlement Funding
Date:4/3/2012

NEW YORK, April 3, 2012 /PRNewswire/ -- Legal-Bay, announced today that their applications for Transvaginal Mesh cases and Kugel Hernia Mesh cases have risen sharply since the company began funding plaintiffs for Mesh cash advances beginning in January 2012.  Most companies within the legal funding industry do not fund Vaginal Mesh or Hernia Mesh Patch cases; however Legal-Bay is an industry leader who is one of the few companies now offering plaintiffs the needed cash to live before their cases go to trial or are settled. 

Settlement Funding experts expect the Transvaginal Mesh cases to go to trial in NJ in 2012, if a global settlement cannot be worked out.  Although the rest of the industry is being very cautious with Mesh cases by refusing to fund plaintiffs of these cases; Legal-Bay stands ready to assist the plaintiffs now – without even knowing the outcome of the litigation.  Not only that, Legal-Bay believes the cases are worth a substantial amount in which Mesh victims can apply for up to $50,000.00 in what is referred to by plaintiffs as a "lawsuit loan".  However, the cash advance is a non-recourse loan in which the victim will owe nothing back if the case ultimately fails. 

Patty Kirby, Head of Customer Relations, commented about the firm's policy on Vaginal and Hernia Mesh settlement funding, "Our product liability funding division has been very busy helping victims of the DePuy Hip Recall, as well as the Vaginal Mesh and Hernia Mesh Cases who have been seeking funding for months and have had no other funders willing to help.  We have secured ample financing to get these individuals lawsuit cash today, regardless of the outcome of their case.  That is what makes our policy different from the rest of the industry; we are not taking a 'wait and see approach', but instead are helping these victims get the money they need today." 

All DePuy, Vaginal and Hernia Mesh victims can apply online at lawsuitssettlementfunding.com or by calling Legal-Bay's 24hr toll free hotline at 877.571.0405, where live agents are standing by 24 hours a day.

Contact:
Patty Kirby, Director of Client Relations
Ph. 877.571.0405
Email: info@legal-bay.com   


'/>"/>
SOURCE Legal-Bay LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pevion Mandated Patient Survey Confirms Disease Burden of Recurrent Vulvovaginal Candidiasis (RVVC) and Indicates Public Health Problem
2. Watson Receives Complete Response Letter from FDA for Progesterone Vaginal Gel 8%
3. Ohio Injury Lawyers Support FDAs Decision for Further Testing of Transvaginal Mesh
4. New Research Demonstrates High Prevalence of Sexually Transmitted Disease Trichomonas Vaginalis and Potential of New Molecular Test to Improve Detection
5. Columbia Laboratories NDA for PROCHIEVE® Vaginal Progesterone Gel Accepted for Filing by FDA
6. Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results
7. Plexus Biomedical Inc. Gains FDA Approval of the First Medical Device to Help Prevent External Hemorrhoids During Vaginal Childbirth
8. Viveve Obtains CE Mark for Gynecologic Treatment of Vaginal Laxity
9. International Menopause Society Calls Upon Medical Community to Improve the Vaginal Health of Postmenopausal Women
10. Gen-Probe Files US Regulatory Application for Molecular Test to Detect Common Sexually Transmitted Disease Trichomonas Vaginalis
11. China Sky One Medical Obtains SFDA Approval for Ciclopirox Olamine Vaginal Suppositories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... PUNE, India , April 19, 2017 ... Type and Application, Forecast to 2022 report has covered and ... provides statistics and information on market size, shares and growth ... with major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and ...
(Date:4/19/2017)... , April 19, 2017 ... stimulate an immune response in pets such as ... products are of various types such as Attenuated ... Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated ... as virus or bacteria, which have been weakend ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 2017 , ... Accreditation Commission for Health Care (ACHC) is ... (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s Home ... University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. , ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Horizon Blue ... affirmed the company’s credit rating of “A” and its outlook as “stable.” At the ... capital reserves, which have fallen in recent years, dip below “capital adequacy” thresholds required ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... . These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on ... or disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, ...
Breaking Medicine News(10 mins):